These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Increase in [11C]vorozole binding to aromatase in the hypothalamus in rats treated with anabolic androgenic steroids. Takahashi K; Hallberg M; Magnusson K; Nyberg F; Watanabe Y; Långström B; Bergström M Neuroreport; 2007 Jan; 18(2):171-4. PubMed ID: 17301684 [TBL] [Abstract][Full Text] [Related]
23. Synthesis, in vivo rhesus monkey biodistribution and in vitro evaluation of a 11C-labelled potent aromatase inhibitor: [N-methyl-11C]vorozole. Lidström P; Bonasera TA; Kirilovas D; Lindblom B; Lu L; Bergström E; Bergström M; Westlin JE; Långström B Nucl Med Biol; 1998 Jul; 25(5):497-501. PubMed ID: 9720668 [TBL] [Abstract][Full Text] [Related]
24. PET imaging evaluation of [(18)F]DBT-10, a novel radioligand specific to α7 nicotinic acetylcholine receptors, in nonhuman primates. Hillmer AT; Zheng MQ; Li S; Scheunemann M; Lin SF; Holden D; Labaree D; Ropchan J; Teodoro R; Deuther-Conrad W; Carson RE; Brust P; Huang Y Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):537-47. PubMed ID: 26455500 [TBL] [Abstract][Full Text] [Related]
25. A new positron emission tomography imaging agent for the serotonin transporter: synthesis, pharmacological characterization, and kinetic analysis of [11C]2-[2-(dimethylaminomethyl)phenylthio]-5-fluoromethylphenylamine ([11C]AFM). Huang Y; Hwang DR; Bae SA; Sudo Y; Guo N; Zhu Z; Narendran R; Laruelle M Nucl Med Biol; 2004 Jul; 31(5):543-56. PubMed ID: 15219271 [TBL] [Abstract][Full Text] [Related]
26. PET imaging of brain aromatase in humans and rhesus monkeys by Takahashi K; Hosoya T; Onoe K; Mori T; Tazawa S; Mawatari A; Wada Y; Watanabe Y; Doi H; Watanabe Y Sci Rep; 2021 Dec; 11(1):23623. PubMed ID: 34880350 [TBL] [Abstract][Full Text] [Related]
27. Novel Kappa Opioid Receptor Agonist as Improved PET Radiotracer: Development and in Vivo Evaluation. Li S; Zheng MQ; Naganawa M; Gao H; Pracitto R; Shirali A; Lin SF; Teng JK; Ropchan J; Huang Y Mol Pharm; 2019 Apr; 16(4):1523-1531. PubMed ID: 30726092 [TBL] [Abstract][Full Text] [Related]
28. Association between aromatase in human brains and personality traits. Takahashi K; Hosoya T; Onoe K; Takashima T; Tanaka M; Ishii A; Nakatomi Y; Tazawa S; Takahashi K; Doi H; Wada Y; Watanabe Y Sci Rep; 2018 Nov; 8(1):16841. PubMed ID: 30442903 [TBL] [Abstract][Full Text] [Related]
29. Increase in hypothalamic aromatase in macaque monkeys treated with anabolic-androgenic steroids: PET study with [11C]vorozole. Takahashi K; Onoe K; Doi H; Nagata H; Yamagishi G; Hosoya T; Tamura Y; Wada Y; Yamanaka H; Yokoyama C; Mizuma H; Takashima T; Bergström M; Onoe H; Långström B; Watanabe Y Neuroreport; 2011 May; 22(7):326-30. PubMed ID: 21460751 [TBL] [Abstract][Full Text] [Related]
30. Pre-clinical characterization of [11C]R05013853 as a novel radiotracer for imaging of the glycine transporter type 1 by positron emission tomography. Borroni E; Zhou Y; Ostrowitzki S; Alberati D; Kumar A; Hainzl D; Hartung T; Hilton J; Dannals RF; Wong DF Neuroimage; 2013 Jul; 75():291-300. PubMed ID: 22178811 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of distribution of adenosine A2A receptors in normal human brain measured with [11C]TMSX PET. Mishina M; Ishiwata K; Kimura Y; Naganawa M; Oda K; Kobayashi S; Katayama Y; Ishii K Synapse; 2007 Sep; 61(9):778-84. PubMed ID: 17568431 [TBL] [Abstract][Full Text] [Related]
32. Preclinical pharmacological evaluation of letrozole as a novel treatment for gliomas. Dave N; Chow LM; Gudelsky GA; LaSance K; Qi X; Desai PB Mol Cancer Ther; 2015 Apr; 14(4):857-64. PubMed ID: 25695958 [TBL] [Abstract][Full Text] [Related]
33. In vivo evaluation of [11C]N-(2-chloro-5-thiomethylphenyl)-N'-(3-methoxy-phenyl)-N'-methylguanidine ([11C]GMOM) as a potential PET radiotracer for the PCP/NMDA receptor. Waterhouse RN; Slifstein M; Dumont F; Zhao J; Chang RC; Sudo Y; Sultana A; Balter A; Laruelle M Nucl Med Biol; 2004 Oct; 31(7):939-48. PubMed ID: 15464396 [TBL] [Abstract][Full Text] [Related]
34. Initial Evaluation of an Adenosine A Sakata M; Ishibashi K; Imai M; Wagatsuma K; Ishii K; Zhou X; de Vries EFJ; Elsinga PH; Ishiwata K; Toyohara J J Nucl Med; 2017 Sep; 58(9):1464-1470. PubMed ID: 28280214 [No Abstract] [Full Text] [Related]
35. In vitro evaluation of aromatase enzyme in granulosa cells using a [11C]vorozole binding assay. Kirilovas D; Bergström M; Bonasera TA; Bergström-Pettermann E; Naessen T; Holte J; Carlström K; Simberg N; Långström B Steroids; 1999 Apr; 64(4):266-72. PubMed ID: 10399883 [TBL] [Abstract][Full Text] [Related]
36. First-in-Human Assessment of the Novel PDE2A PET Radiotracer 18F-PF-05270430. Naganawa M; Waterhouse RN; Nabulsi N; Lin SF; Labaree D; Ropchan J; Tarabar S; DeMartinis N; Ogden A; Banerjee A; Huang Y; Carson RE J Nucl Med; 2016 Sep; 57(9):1388-95. PubMed ID: 27103022 [TBL] [Abstract][Full Text] [Related]
37. PET brain imaging of neuropeptide Y2 receptors using N-11C-methyl-JNJ-31020028 in pigs. Winterdahl M; Audrain H; Landau AM; Smith DF; Bonaventure P; Shoblock JR; Carruthers N; Swanson D; Bender D J Nucl Med; 2014 Apr; 55(4):635-9. PubMed ID: 24614224 [TBL] [Abstract][Full Text] [Related]
38. Measurement of glycine binding site of N-methyl-D-asparate receptors in living human brain using 4-acetoxy derivative of L-703,717, 4-acetoxy-7-chloro-3-[3-(4-[11c] methoxybenzyl) phenyl]-2(1H)-quinolone (AcL703) with positron emission tomography. Matsumoto R; Haradahira T; Ito H; Fujimura Y; Seki C; Ikoma Y; Maeda J; Arakawa R; Takano A; Takahashi H; Higuchi M; Suzuki K; Fukui K; Suhara T Synapse; 2007 Oct; 61(10):795-800. PubMed ID: 17598152 [TBL] [Abstract][Full Text] [Related]